
Legence (NasdaqGS:LGN) reported material impairments to goodwill and long-lived assets for Q2 2026. The company also revised its full year 2026 revenue guidance upward. The combination of asset impairments and a stronger revenue outlook highlights a mixed update for investors assessing Legence's prospects. This type of update, where a company reassesses asset values while lifting its revenue outlook, is common across several stocks exposed to similar themes. This makes it worth comparing...


